Graduate training at the interface of two fields such as chemistry and biology offers students a unique perspective and skills to lead basic and applied biomedical research. A fluency in both fields can inspire cross-disciplinary approaches for solving problems that may not be considered within the traditions of a single field. This proposal requests renewed support for the Chemistry Biology Interface Training program (CBI) at Johns Hopkins University (JHU). The program operates as an independent degree-granting organization that has nucleated a vibrant community of investigators from The School of Public Health (Biochemistry and Molecular Biology), The Medical School (Biophysics and Biophysical Chemistry, Pharmacology), The Kreiger School of Arts and Sciences (Biology, Biophysics, Chemistry) and The School of Engineering (Chemical and Biomolecular Engineering). Select faculty from these seven departments have joined together to lead the academic and administrative structure of this program. Supplementary funds are contributed by the departments and The Krieger School to help sustain this autonomous program. Prospective students apply directly to the CBI program and arrive in a cohort that shares a common curriculum. Courses are designed to reinforce a strong foundation in chemistry while building expertise in the biological sciences. A series of three laboratory rotations across different departments ensures a breadth of experience in research prior to selection of a dissertation advisor. A diverse array of research topics are available from the 29 faculty participating in the CBI program and include drug development, bioinorganic chemistry, enzymology, nucleic acids, and biomolecular structure, assembly and dynamics. A two-semester graduate course in chemical biology offers core instruction for the CBI program and is also open to all at JHU. Students remain active in the CBI program throughout their matriculation by participating in student-hosted seminars, literature meetings and an annual retreat. In addition, all CBI students join the monthly CBI Forum to hear and present research updates and independent proposals as well as faculty introductions and information pertaining to career and professional development. The CBI program was initiated with seed funds from the University in 2005 and first received NIH support in 2007. These funds are sufficient too support only 5 students. The current proposal requests funds for 6 students to reduce the necessity of turning away qualified applications. In the last funding cycle, student retention has been very high (95%) and over 90% since the start of the program.

Public Health Relevance

The interface of chemistry and biology is particularly rich with opportunities to advance basic and applied biomedical research. The Chemistry-Biology Interface graduate program at Johns Hopkins University is designed to train the next generation of scientists with a strong foundation in chemistry and an expertise in research on topics critical to biology.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM080189-11
Application #
9490818
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Fabian, Miles
Project Start
2008-07-01
Project End
2023-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
11
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Cohen, Douglas R; Townsend, Craig A (2018) A dual role for a polyketide synthase in dynemicin enediyne and anthraquinone biosynthesis. Nat Chem 10:231-236
Johnson, Eric A; Russo, Miranda M; Nye, Dillon B et al. (2018) Lysine as a heme iron ligand: A property common to three truncated hemoglobins from Chlamydomonas reinhardtii. Biochim Biophys Acta Gen Subj 1862:2660-2673
Saraiva, Raúl G; Huitt-Roehl, Callie R; Tripathi, Abhai et al. (2018) Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin. Sci Rep 8:6176
Sanders, Sara; Bartee, David; Harrison, Mackenzie J et al. (2018) Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors. PLoS One 13:e0197638
Herbst, Dominik A; Huitt-Roehl, Callie R; Jakob, Roman P et al. (2018) The structural organization of substrate loading in iterative polyketide synthases. Nat Chem Biol 14:474-479
Nye, Dillon B; Preimesberger, Matthew R; Majumdar, Ananya et al. (2018) Histidine-Lysine Axial Ligand Switching in a Hemoglobin: A Role for Heme Propionates. Biochemistry 57:631-644
Singh, Digvijay; Wang, Yanbo; Mallon, John et al. (2018) Mechanisms of improved specificity of engineered Cas9s revealed by single-molecule FRET analysis. Nat Struct Mol Biol 25:347-354
Bartee, David; Freel Meyers, Caren L (2018) Toward Understanding the Chemistry and Biology of 1-Deoxy-d-xylulose 5-Phosphate (DXP) Synthase: A Unique Antimicrobial Target at the Heart of Bacterial Metabolism. Acc Chem Res 51:2546-2555
Boucher, Lauren E; Hopp, Christine S; Muthinja, Julianne Mendi et al. (2018) Discovery of Plasmodium (M)TRAP-Aldolase Interaction Stabilizers Interfering with Sporozoite Motility and Invasion. ACS Infect Dis 4:620-634
Nye, Dillon B; Lecomte, Juliette T J (2018) Replacement of the Distal Histidine Reveals a Noncanonical Heme Binding Site in a 2-on-2 Hemoglobin. Biochemistry 57:5785-5796

Showing the most recent 10 out of 82 publications